NET PROFIT (x1000 SEK)
EMPLOYEES
Enza Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-8,904
|
-8,645
|
-7,802 |
EBITDA |
-8,293
|
-8,029
|
-7,227 |
Total assets |
5,534
|
5,503
|
5,835 |
Current assets |
2,304
|
1,812
|
1,701 |
Current liabilities |
1,772
|
1,037
|
925 |
Equity capital |
3,762
|
4,466
|
4,910 |
- share capital |
276
![]() |
276
![]() |
276 |
Employees (average) |
5
![]() |
5
![]() |
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.0%
|
81.2%
|
84.1% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-160.9%
|
-157.1%
|
-133.7% |
Current ratio |
130.0%
|
174.7%
|
183.9% |
Return on equity (ROE) |
-236.7%
|
-193.6%
|
-158.9% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.